jgrabar
4 월 전
https://markets.businessinsider.com/news/stocks/alert-to-longterm-investors-of-the-scotts-miraclegro-company-smg-grabar-law-office-is-investigating-claims-on-your-behalf-1033562551
WHAT YOU CAN DO NOW: Current Scotts shareholders who have held Scotts shares since on or before November 1, 2021, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them whatsoever.
If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/Scotts-Shareholder-Investigation/, contact Joshua Grabar at jgrabar @FH-6085.
Attorney Advertising Disclaimer
sirius22
2 년 전
Nope not the time to buy as long as SMG has Hawthorne pulling it down.
It’s funny to me, wondering how many people on this board reading this post actually believe in any way that the reason Hawthorne is doing poorly has anything to do with the cannabis market in the US as far as overproduction. I mean, that excuse doesn’t even make sense which should show you how disconnected these people are from Cannabis.
Hawthornes slow motion but colossal failure is straight up the result of Hawthorne going to grow bro idiots who have been operating in their garage and assuming that they knew what products and equipment would be needed to scale. Spoiler alert, they had no idea what was required to scale.
I work in California cannabis at agricultural scale indoor, outdoor, greenhouse and have been involved with around 40% of the states licensed cannabis canopy. I can tell you with 100% certainty that l absolutely none of the brands/products/equipment that you find in a grow/hydro store that were purchased by Hawthorne like Cann Fan, Botanicare nutrients, etc. are used at any significant scale other than for the home grower and that’s it.
It has never ceased to amaze me that a blue chip company like SMG would eff up this bad as far as just simply not even doing any due diligence as to what the market really looked like down the road and what products or product type/formats would be appropriate for that.
Even before Scott’s bought all of these companies people had already begun to scale above and beyond the type of equipment offered by the companies Hawthorne acquired.
map35
4 년 전
SMG is growing because they own a bunch of hydroponic companies including General Hydroponics (nutrients), Gavita (commercial lighting), environmental controls and more under their subsidiary Hawthorne. https://www.hawthornegc.com/page/signature-brands No cannabis grower uses SMG oil. They either use coco coir, complete hydro, or organic live soil, sometimes fox farm soils.
As more Grow facilities are built SMG will have a significant revenue stream.
Gavita grow lights are a staple in many commercial grows and can be seen on YouTube shows cannacribs and growing exposed.
Pennystomper55
4 년 전
Another great day, Scotts just keeps going up. Interesting news yesterday too, should help keep their products the best on the market.
Flowr and Hawthorne Canada Jointly Announce the Completion of the World's First Cannabis Research and Development Facility of its Kind
8:00 am ET January 5, 2021 (Globe Newswire) Print
North America's first research and development facility dedicated to advancing cannabis cultivation techniques and systems has been completed by The Flowr Corporation (TSXV: FLWR) and Hawthorne Canada Limited ("Hawthorne"). Hawthorne is a subsidiary of the Hawthorne Gardening Company division of The Scotts Miracle-Gro Company (NYSE:SMG). Scotts Miracle-Gro is the world's leading marketer of branded consumer lawn and garden products and indoor growing solutions. Flowr cultivates and sells premium cannabis to medical and adult-use markets in Canada, Europe and Australia.
Located on Flowr's cultivation campus in Kelowna, British Columbia, Canada, the R&D Center includes state-of-the-art laboratories, indoor grow suites, and training areas in a single building. Flowr will test cultivation systems and techniques using Hawthorne's advanced lighting, fertilization and irrigation systems, growing mediums, and research protocols. In addition, Flowr intends to focus its own research on cannabis genetics and integrated growing systems in line with its goal of delivering premium quality cannabis products through highly efficient cultivation.
"We built Hawthorne to help cultivators of all sizes grow quality plants with high levels of efficiency and consistency. Completing the industry's only dedicated R&D facility gives us a distinct advantage. We will leverage Flowr's cultivation expertise and our technical capabilities into real world testing and results that will make a difference to growers," said Chris Hagedorn, SVP & General Manager of Hawthorne Gardening. "We are proud of this collaboration with Flowr, a leading international cannabis company, with extensive growing experience indoors, in greenhouses and at-scale outdoors. Flowr is also one of a few companies that have had experience growing diverse genetics in different countries. We believe this experience will benefit our companies and the growers we serve."
"The completion of the R&D Center brings our work with Hawthorne fully to life and will help keep both companies on the leading edge of cannabis cultivation for years to come," commented Lance Emanuel, President and Interim Chief Executive Officer of Flowr. "Operationalizing the R&D Center is a major accomplishment for our organization and strengthens our competitive advantage in cultivation. We believe the long-term success of Flowr will be rooted in our ability to maximize the cannabinoid and terpene expression of genetics without sacrificing yield. The work we will do at the R&D Center will help us build upon the success we've had producing high quality, premium cannabis like our award-winning, flagship-strain BC Pink Kush beloved by budtenders and consumers throughout Canada. Leveraging our work at the R&D Center will be imperative to our eventual entry into the United States once federally permissible by law."
The R&D Center is the centerpiece of a strategic R&D partnership formed by Flowr and Hawthorne in March 2018. It brings two of the world's leading experts together to be at the forefront of cannabis cultivation. The operations will be led by Dr. Deron Caplan, the first person in North America to earn a PhD focused on cannabis cultivation and production. Dr. Caplan was awarded his doctorate by the University of Guelph in August 2018 and is Flowr's Director of Research and Development. The R&D Center will be staffed by Flowr's scientists, five of whom have PhDs in various plant biology, plant genetics and plant biochemistry disciplines. Hawthorne R&D will lead the research design and methodology.
All requisite licensing from Health Canada has been obtained by Flowr and the expectation is that the R&D Center will be operating at full capacity in Spring 2021. Research has already begun conducting growing trials at scale using Hawthorne products.
https://www.globenewswire.com/NewsRoom/AttachmentNg/ed973b58-e705-4797-9c77-71ca226d3cf8
Pictured: The Hawthorne R&D Center, from Flowr's Kelowna Campus in British Columbia.
About Hawthorne Gardening Company
Pennystomper55
4 년 전
More good news,
The company increased its guidance again this year, SCOTTS IS KILLING IT!
The Scotts Miracle-Gro Company SMG has provided an update for its fiscal 2020 view. The company expects net sales and adjusted earnings per share (EPS) to surpass its prior guidance issued in July.
For fiscal 2020 (ending Sep 30, 2020), the company now projects adjusted EPS to be around $7.25 compared with previous guidance of $6.65-$6.85. This is likely to be driven by company-wide sales growth of more than 30%.
Per Scotts Miracle-Gro, the momentum in the U.S. Consumer and Hawthorne segments is exceeding the company’s expectations. Its key business drivers over the past six months have been highly engaged retailer support and strong consumer demand. The company expects the trend to continue into the first quarter of fiscal 2021. Further, it expects lower expenses to act as tailwind next year.
Shares of Scotts Miracle-Gro have rallied 58% in the past year against the industry’s 12.6% decline.
Hot Features
프리미엄
같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Monksdream
1 월 전
MiamiGent
1 년 전
stocksrising
2 년 전
Liam859
2 년 전
BottomBounce
3 년 전
Nebuchadnezzar
3 년 전
whytestocks
4 년 전
nowwhat2
6 년 전
